
|Articles|November 1, 2003
VACCINE LAUNCH EXPECTED
CancerVax expects to launch its therapeutic melanoma vaccine and lead product candidate Canvaxin by 2006.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
The “6-7” Advances for Dermatologists to Look Forward to in 2026
2
Soquelitinib Phase 1 Data Show Sustained Clinical Improvement With Extended Treatment in AD
3
Clinicians See Intersection of Weight Loss and Facial Aging
4
Exploring Type 2 Inflammation and Psoriasis Management at Horizons in Advanced Practice
5


















